Our specialists help our clients define their strategy and objectives, assemble a credible narrative, marshal the relevant facts, and define a message that resonates with your audience. We then help you present it convincingly. As public affairs specialists, our role is to advise you on how best to argue – and support – your case. We are not intermediaries, but we can help broker meetings with relevant stakeholders and provide ongoing public affairs advice and assistance on next steps.
We also can bring extra support and manpower to your in-house teams where needed, including project execution and training and development.
At an EU level, Fipra International organises its expertise into specific practices:
The head of our Brexit Team, Lucinda Creighton, ran the last Irish EU Presidency, and was until recently Minister for European Affairs in Ireland. At Fipra, Lucinda is closely assisted by a team of EU experts, including former senior members of the European Commission and European Parliament, as well as political intelligence and analysis gathered from our network of offices and professional political advisers present in every EU Member State.
The Fipra Competition Practice has been advising clients on the public affairs aspects of competition policy cases for more than 15 years. We have advised on over 100 mergers and acquisitions, typically those raising specific competition concerns and/or wider public policy issues. These have ranged from international and EU cross-border transactions to smaller cases under national jurisdictions. We have also advised on many anti-trust cases, including the operation of existing markets, new market entry, alleged abuse of a dominant position, State aid cases, copyright and trademark issues and cartels.
More than ten years’ experience of counselling over 100 clients, ranging from energy producers to extractive industries, on policy and regulatory issues, the implications of policy initiatives and the engagement required.
The Fipra Chemicals, Industrials and Mining (CIM) practice has been assisting clients in an array of industries, including coatings, detergents, minerals and metals since 2000. Given the breadth of challenges in the sector, we maintain an experienced staff and a range of Special Advisers with a wide range of expertise in the regulatory and policy aspects facing CIM industries.
Financial Services is one of the longest established Fipra practice areas. Our experts have guided our clients through some of the highest-profile political and regulatory challenges in recent years, including the global financial crisis that forced governments and regulators to radically reshape the banking and financial services landscape.
The Fipra Healthcare and Food Practice has advised over 150 clients in the last ten years. We have helped deliver political and policy change on issues of public health, food and nutrition, pharmaceuticals and medical devices in the EU and in over 50 markets globally.
Fipra has maintained a Travel, Transport and Logistics (TTL) practice since 2000. We have a demonstrable record of working closely and constructively with political and regulatory bodies, including local and national governments, in more than 25 countries.
Our Digital and Tech group has advised leading e-commerce platforms, sharing-economy players and apps developers, along with other high-tech, media and telecommunications firms. We have worked with coalitions of high-tech companies on broad issues, giving them an effective voice while legislation and guidelines are under development. We also coordinated one-stop shop government relations campaigns for disruptive industries in a rapidly expanding list of countries in Europe, Africa, Asia and Latin America.
The Fipra International Trade practice has advised and assisted clients across a wide range of trade issues. These include bilateral free trade and investment agreements (FTAs), multilateral negotiations and the World Trade Organisation (WTO), regulatory cooperation and anti-dumping cases.
Fipra was established in Spring 2000 to provide advice to clients on European Union political and regulatory affairs. We now have a presence in every EU and European Economic Area (EEA) Member State. Our network of experienced public affairs experts now extends to more than 50 countries, including Australia, Brazil, Canada, China, India, Japan, South Korea and Turkey. We operate in individual countries or across borders to meet your regulatory affairs needs.
Navigating unfamiliar political and regulatory environments is challenging. Fipra will guide you, helping you build effective relationships while developing and delivering effective localised messages.
From our roots in Europe, Fipra is now active in every continent. The worldwide expansion in our regulatory affairs specialists reflects both the range of our international clients and their need for public affairs support that understands the growing internationalisation of business, politics and regulation. Today, large-scale mergers and acquisitions by worldwide corporations require approval from competition authorities in the European Union, the United States, China and other jurisdictions.
We provide a one-stop service for developing a coordinated, coherent and consistent global public affairs campaign and policy narrative, wherever you operate. You benefit from both our global coordination and our local government relations expertise.
Fipra International Ltd is the coordinator of the Fipra network, marketing and sales. It is responsible for licensing the Fipra brand.
Fipra representatives in each country are experienced public affairs consultants in their own right, licensed to represent Fipra in that country. Each unit has a network of experienced advisers with sector-specific knowledge, able to provide high-level expertise.
Belarus 
Belgium 
Bulgaria 
Croatia 
Cyprus 
Czech Republic 
Denmark 
Estonia 
Finland 
France 
Germany 
Greece 
Hungary 
Iceland 
Ireland 
Italy 
Latvia 
Lithuania 
Luxembourg 
Malta 
Netherlands 
Norway 
Poland 
Portugal 
Romania 
Russia 
Slovakia 
Slovenia 
South Africa 
Spain 
Sweden 
Switzerland 
Turkey 
Ukraine 
United Kingdom 
Brazil 
Canada 
Colombia 
United States 
Australia 
China 
India 
Japan 
Korea 
Saudi Arabia 
Singapore 
